Florida / New York

Medical Device News Magazine

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Day: October 15, 2020

XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure Using PASylation® Technology

Medical Device News Magazine0

Brian Johnson, Antlia Bioscience’s CEO commented, “chronic heart failure is a significantly unaddressed medical condition and a major public health concern. XL-protein’s PASylation® technology will allow us to safely and effectively translate our peptide into a meaningful therapeutic option for patients with chronic heart failure.

Read More
Request Information
Contact Us
Where to read Medical Device News

Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved

Hours:

M – F 8 am – 5 pm

Florida / New York

Phone: 561.316.3330